Table 1
Clinicopathological features and telomerase activity in pancreatic endocrine tumours (PETs)
| Case/Race | Sex/Age | Site | Tumour type | Size (diameter) of PETs | Telomerase activity | Optical density | Treatment | Follow up (months) | Remarks |
|---|---|---|---|---|---|---|---|---|---|
| ACTH, adrenocorticotrophin; MEN 1, multiple endocrine neoplasia type 1; NED, no evidence of disease. | |||||||||
| 1/Chinese | M/46 | Head | Insulinoma | 1.5 cm | Negative | – | Enucleation | 52, alive, NED | |
| 2/Chinese | M/41 | Multiple | Insulinoma | Multiple tumors, the largest one: 6.0 cm at tail | Negative | – | Distal subtotal pancreatectomy | 46, alive NED | Had MEN 1 |
| 3/Chinese | F/43 | Body | Malignant ACTH producing PET | 1.0 cm | Positive | 1.9 | Distal pancreotomy | 18, died | Metastases in liver |
| 4/Chinese | M/22 | Multiple | Insulinoma | Multiple tumours, the largest one: 1.0 cm at tail | Positive | 1.9 | Distal subtotal pancreatectomy | 36, alive NED | Had MEN 1 |
| 5/Indian | F/49 | Tail | Insulinoma | 1.5 cm | Negative | – | Enucleation | 16, alive, NED | |
| 6/Chinese | M/29 | Body | Insulinoma | 1.5 cm | Negative | – | Distal pancreatectomy | 21, alive NED | |
| 7/Chinese | F/64 | Tail | Malignant insulinoma | 7.0 cm | Positive | 1.4 | Distal pancreatectomy | 15, alive with residual disease | Metastases in liver |
| 8/Chinese | M/35 | Tail | Insulinoma | 1.5 cm | Negative | – | Distal pancreatectomy | 11, alive NED | |
| 9/Chinese | M/68 | Head | Insulinoma | 1.0 cm | Negative | – | Enucleation | 4, alive, NED | |
| 10/Chinese | F/65 | Head | Insulinoma | 1.5 cm | Negative | – | Enucleation | 3, alive, NED | |
